784-38-3

应用筛选条件

关键词:'784-38-3'

显示 1-2 共 2 条结果关于 "784-38-3" 范围论文

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.

David Mischoulon et al.

The Journal of clinical psychiatry, 70(12), 1636-1644 (2009-08-28)

To examine the efficacy and tolerability of ethyl-eicosapentaenoate (EPA-E) monotherapy for major depressive disorder (MDD). Fifty-seven adults with DSM-IV MDD were randomly assigned from January 2003 until June 2006 to receive 1 g/d of eicosapentaenoic acid (EPA) or placebo for

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

Fred Saad et al.

The Lancet. Oncology, 16(3), 338-348 (2015-02-24)

Orteronel is an investigational, partially selective inhibitor of CYP 17,20-lyase in the androgen signalling pathway, a validated therapeutic target for metastatic castration-resistant prostate cancer. We assessed orteronel in chemotherapy-naive patients with metastatic castration-resistant prostate cancer. In this phase 3, double-blind

1/1